日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Homologous recombination deficiency and hemizygosity drive resistance in breast cancer

同源重组缺陷和半合子状态是乳腺癌耐药性的驱动因素

Safonov, Anton; Lee, Minna; Brown, David N; Boscolo Bielo, Luca; Mehine, Miika; Bandlamudi, Chaitanya; O'Leary, Ben; Shao, Hong; Vicente, Laia; Muldoon, Daniel; Zhu, Allen; Ros, Susana; Marra, Antonio; Selenica, Pier; Bieche, Ivan; Wubbenhorst, Bradley; Ferraro, Emanuela; Courtois, Laura; El Botty, Rania; Ahmed, Mehnaj; Moiso, Enrico; An, Julia Ah-Reum; Donoghue, Mark T A; Will, Marie; Pareja, Fresia; Nizialek, Emily; Lukashchuk, Natalia; Sofianopoulou, Eleni; Liu, Yuan; Huang, Xin; Chappey, Colombe; Staniszewska, Anna D; Ross, Dara; Mandelker, Diana; Ladanyi, Marc; Schultz, Nikolaus; Berger, Michael F; Scaltriti, Maurizio; Reis-Filho, Jorge S; Li, Bob T; Offit, Kenneth; Norton, Larry; Shen, Ronglai; Maxwell, Kara N; Couch, Fergus; Domchek, Susan M; Marangoni, Elisabetta; Shah, Sohrab; Albertella, Mark R; Serra, Violeta; Weigelt, Britta; Solit, David B; Nathanson, Katherine L; Robson, Mark E; Turner, Nicholas C; Chandarlapaty, Sarat; Razavi, Pedram

CD36 enhances sensitivity of triple negative breast cancer cells to palmitate-induced ferroptosis.

CD36 增强三阴性乳腺癌细胞对棕榈酸酯诱导的铁死亡的敏感性。

Closset Lara, Foy Jean-Philippe, Louadj Lila, Pramil Elodie, Marangoni Elisabetta, Bieche Ivan, Sabbah Michèle

Targeting PRMTs Creates Vulnerability of DNA Double-Stand Break Repair Pathways, and Potentiates Chemotherapy Efficacy in TNBC

靶向PRMTs可破坏DNA双链断裂修复通路,并增强TNBC的化疗疗效。

Thiebaut, Charlène; Martinez, Sébastien; Pruvost, Ludivine; Eve, Louisane; El-Botty, Rania; Sourd, Laura; Montaudon, Elodie; Dahmani, Ahmed; Derrien, Heloise; Sentis, Stéphanie; Poulard, Coralie; Marangoni, Elisabetta; Trédan, Olivier; Le Romancer, Muriel

SCANDARE: an institutional dynamic prospective interventional biobanking study

SCANDARE:一项机构动态前瞻性干预性生物样本库研究

Lamy, Constance; Laurent, Léonard; Choussy, Olivier; Pouget, Nicolas; Lecuru, Fabrice; Reyal, Fabien; Plissonnier, Anne-Sophie; Kadi, Amir; Berger, Frédérique; Martin, Joey; Dubray-Vautrin, Antoine; Marret, Grégoire; Borcoman, Edith; Romano, Emanuela; Sablin, Marie-Paule; Cabel, Luc; Pasquesoone, Camille; Lantz, Olivier; Louis, Delphine; Gorret, Doriane; Da Silva, Ines Dias; Mariani, Odette; Delattre, Olivier; Bièche, Ivan; Servant, Nicolas; Rodrigues, Manuel; Pierga, Jean-Yves; Seban, Romain-David; Marangoni, Elisabetta; Morillon, Antonin; Théry, Clotilde; Proudhon, Charlotte; Piaggio, Eliane; Vallot, Céline; Mechta-Grigoriou, Fatima; Flavius, Julie; Dupain, Célia; Gentric, Géraldine; Vincent-Salomon, Anne; Kamal, Maud; Le Tourneau, Christophe

Force transmission is a master regulator of mechanical cell competition.

力传递是细胞机械竞争的主要调节因素

Schoenit Andreas, Monfared Siavash, Anger Lucas, Rosse Carine, Venkatesh Varun, Balasubramaniam Lakshmi, Marangoni Elisabetta, Chavrier Philippe, Mège René-Marc, Doostmohammadi Amin, Ladoux Benoit

Targeting ferroptosis resistance resensitizes metastatic HR(+)HER2(-) breast cancer cells to palbociclib-hormone therapy

靶向铁死亡抵抗可使转移性 HR(+)HER2(-) 乳腺癌细胞对帕博西尼联合激素疗法重新敏感

Pottier, Charles; Montero-Ruiz, Laetitia; Jehay, Robin; Wery, Coline; Baiwir, Dominique; Mazzucchelli, Gabriel; Bekisz, Sophie; Thissen, Romain; Josse, Claire; Rorive, Andrée; Gofflot, Stéphanie; Dahmani, Ahmed; Morisset, Ludivine; Collignon, Joëlle; Delvenne, Philipe; Marangoni, Elisabetta; Noël, Agnès; Jerusalem, Guy; Sounni, Nor Eddine

Dynamic forces shape the survival fate of eliminated cells

动态因素决定了被淘汰细胞的存活命运。

Balasubramaniam, Lakshmi; Monfared, Siavash; Ardaševa, Aleksandra; Rosse, Carine; Schoenit, Andreas; Dang, Tien; Maric, Chrystelle; Hautefeuille, Mathieu; Kocgozlu, Leyla; Chilupuri, Ranjith; Dubey, Sushil; Marangoni, Elisabetta; L Doss, Bryant; Chavrier, Philippe; Mège, René-Marc; Doostmohammadi, Amin; Ladoux, Benoit

Curcumin Induces Homologous Recombination Deficiency by BRCA2 Degradation in Breast Cancer and Normal Cells.

姜黄素通过降解乳腺癌细胞和正常细胞中的 BRCA2 诱导同源重组缺陷

Komar Zofia M, Ladan Marjolijn M, Verkaik Nicole S, Dahmani Ahmed, Montaudon Elodie, Marangoni Elisabetta, Kanaar Roland, Nonnekens Julie, Houtsmuller Adriaan B, Jager Agnes, Gent Dik C van

Patient-Derived Xenografts of Triple-Negative Breast Cancer Enable Deconvolution and Prediction of Chemotherapy Responses.

源自患者的三阴性乳腺癌异种移植模型能够对化疗反应进行解卷积和预测

Lei Jonathan T, Dobrolecki Lacey E, Huang Chen, Srinivasan Ramakrishnan R, Vasaikar Suhas V, Lewis Alaina N, Sallas Christina, Zhao Na, Cao Jin, Landua John D, Moon Chang In, Liao Yuxing, Hilsenbeck Susan G, Osborne C Kent, Rimawi Mothaffar F, Ellis Matthew J, Petrosyan Varduhi, Wen Bo, Li Kai, Saltzman Alexander B, Jain Antrix, Malovannaya Anna, Wulf Gerburg M, Marangoni Elisabetta, Li Shunqiang, Kraushaar Daniel C, Wang Tao, Damodaran Senthil, Zheng Xiaofeng, Meric-Bernstam Funda, Echeverria Gloria V, Anurag Meenakshi, Chen Xi, Welm Bryan E, Welm Alana L, Zhang Bing, Lewis Michael T

Targeted dual degradation of HER2 and EGFR obliterates oncogenic signaling, overcomes therapy resistance, and inhibits metastatic lesions in HER2-positive breast cancer models.

针对 HER2 和 EGFR 的双重靶向降解可消除致癌信号传导,克服治疗耐药性,并抑制 HER2 阳性乳腺癌模型中的转移病灶

Yang Lu, Bhattacharya Arup, Peterson Darrell, Li Yun, Liu Xiaozhuo, Marangoni Elisabetta, Robila Valentina, Zhang Yuesheng